Boston Scientific Corp. has exercised its option to acquire the remaining shares of University of Iowa startup Farapulse Inc., which has developed a method for precisely and safely treating abnormal heart rhythms.
Research on faulty genetic material by University of Iowa (UI) Carver College of Medicine professor Christopher Ahern recently was licensed by Tevard Biosciences, a company that is seeking to treat certain forms of epilepsy.
With federal funding from the Iowa Governor’s Office, researchers at the University of Iowa are working to help create a nanovaccine that would protect against the virus that causes COVID-19 and be administered via nasal spray rather than a needle.
The State Hygienic Laboratory (SHL) has been in the spotlight since the beginning of the COVD-19 pandemic.
The following message from Vice President for Research Marty Scholtz was shared with campus on Wednesday, May 27, 2020.
The National Academy of Inventors (NAI) has named University of Iowa cystic fibrosis and gene therapy researcher John Engelhardt, PhD, a 2019 Fellow. Engelhardt, who is professor and head of anatomy and cell biology in the UI Carver College of Medicine and director of the UI Center for Gene Therapy, is recognized for his work in developing gene therapies to treat cystic fibrosis (CF).
It’s never too early to start strategizing about how to write a winning grant proposal that will get attention and bring in research funding.
The National Academy of Inventors (NAI) has named University of Iowa neurosurgeon and entrepreneur Matthew Howard, M.D., a 2018 fellow.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy.
University of Iowa startup and medical device developer iotaMotion Inc. has raised $2 million in a seed financing round to fuel the development of novel robotic systems for cochlear implantation surgery.
